Medtronic RESCUE (Evaluation of the Clinical PeRformanceE of the Valiant Thoracic Stent Graft with the Captivia Delivery System for the EndovaSCUlar TrEatment of Blunt Thoracic Aortic Injuries) clinical
EraGen’s HSV 1&2 Kit is expected to distinguish between HSV-1 and HSV-2 in vaginal lesion specimens from symptomatic female patients. This is critical to the diagnosis and treatment
Ectoin is a cyclic amino acid that is produced mainly by halophilic bacteria to protect the cells from the extreme osmotic stress associated with saline conditions. bitop claimed
The pilot study with to-BBB is expected to allow researchers of Janssen to investigate the capabilities of the G-Technology to enhance delivery of their investigational compounds to the
The patent, titled ‘Treating Neoplasms with Neurotoxin,’ outlines the use of botulinum toxin around the cancer cell to decrease the contractile forces of the muscles surrounding a neoplasm
The joint venture, Angelini Labopharm, is expected to launch Oleptro, Labopharm’s novel once-daily formulation of trazodone indicated for the treatment of major depressive disorder in adults, in the
The Centre for Drug Research and Development (CDRD) provides drug development expertise and infrastructure to enable researchers from leading academic and health research institutions to advance promising, early-stage
COTI Phase 1 results showed that the majority of currently marketed and developmental stage HIV Integrase inhibitors have a very similar way of interacting with and inhibiting the
Reportedly, Ablynx had signed the research collaboration and license agreement with Pfizer (originally signed with Wyeth Pharmaceuticals) in November 2006, a deal potentially worth $212.5m in past and
The results demonstrated that the 2A/Furin technology was integrated successfully into a plasmid-based, industrial-scale, CHO antibody cell line development process, with minimal optimisation required. Use of 2A/Furin could
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.